{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:26:03Z","timestamp":1781216763456,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s11102-023-01316-5","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T03:02:33Z","timestamp":1682650953000},"page":"375-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antiplatelet and anticoagulation therapy and the risk of pituitary apoplexy in pituitary adenoma patients"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-0724","authenticated-orcid":false,"given":"Bronson","family":"Ciavarra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Kole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie B.","family":"Guttenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros L.","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"issue":"4","key":"1316_CR1","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/jnnp.71.4.542","volume":"71","author":"V Biousse","year":"2001","unstructured":"Biousse V, Newman NJ, Oyesiku NM (2001) Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 71(4):542\u2013545. https:\/\/doi.org\/10.1136\/jnnp.71.4.542","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1316_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF02112028","volume":"120","author":"W Bonicki","year":"1993","unstructured":"Bonicki W, Kasperlik-Za\u0141Uska A, Koszewski W, Zgliczynski W, Wis\u0141Awski J (1993) Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas. Acta Neurochir 120:3\u20134. https:\/\/doi.org\/10.1007\/BF02112028","journal-title":"Acta Neurochir"},{"key":"1316_CR3","doi-asserted-by":"publisher","unstructured":"Chang CV, Felicio AC, Toscanini AC, Teixeira MJ (2009) and M. B. C. d. Cunha-Neto, \u201cPituitary tumor apoplexy,\u201c Arquivos de neuro-psiquiatria, vol.\u00a067, no. 2A, pp.\u00a0328\u2013333, https:\/\/doi.org\/10.1590\/S0004-282X2009000200033","DOI":"10.1590\/S0004-282X2009000200033"},{"key":"1316_CR4","doi-asserted-by":"publisher","unstructured":"Cinar N, Tekinel Y, Dagdelen S, Oruckaptan H, Soylemezoglu F, Erbas T (2012) \u201cCavernous sinus invasion might be a risk factor for apoplexy,\u201c Pituitary, vol.\u00a016, no. 4, pp.\u00a0483\u2013489, https:\/\/doi.org\/10.1007\/s11102-012-0444-2","DOI":"10.1007\/s11102-012-0444-2"},{"issue":"2","key":"1316_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1046\/j.1365-2265.1999.00754.x","volume":"51","author":"HS Randeva","year":"1999","unstructured":"Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CBT, Wass JAH (1999) Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxford) 51(2):181\u2013188. https:\/\/doi.org\/10.1046\/j.1365-2265.1999.00754.x","journal-title":"Clin Endocrinol (Oxford)"},{"issue":"1","key":"1316_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0002-9149(97)00862-X","volume":"81","author":"S Fuchs","year":"1998","unstructured":"Fuchs S, Beeri R, Hasin Y, Weiss AT, Gotsman MS, Zahger D (1998) Pituitary Apoplexy as a First Manifestation of Pituitary Adenomas following intensive thrombolytic and antithrombotic therapy. Am J Cardiol 81(1):110\u2013111. https:\/\/doi.org\/10.1016\/S0002-9149(97)00862-X","journal-title":"Am J Cardiol"},{"issue":"2","key":"1316_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3171\/jns.1981.55.2.0187","volume":"55","author":"S Wakai","year":"1981","unstructured":"Wakai S, Fukushima T, Teramoto A, Sano K (1981) Pituitary apoplexy: its incidence and clinical significance. J Neurosurg 55(2):187\u2013193. https:\/\/doi.org\/10.3171\/jns.1981.55.2.0187","journal-title":"J Neurosurg"},{"issue":"1","key":"1316_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/j.1365-2265.1999.00748.x","volume":"51","author":"J Feldkamp","year":"1999","unstructured":"Feldkamp J, Santen R, Harms E, Aulich A, M\u00d6Dder U, Scherbaum WA (1999) Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas results of a prospective study. Clin Endocrinol (Oxford) 51(1):109\u2013113. https:\/\/doi.org\/10.1046\/j.1365-2265.1999.00748.x","journal-title":"Clin Endocrinol (Oxford)"},{"issue":"1","key":"1316_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clineuro.2006.01.006","volume":"109","author":"AS Dubuisson","year":"2006","unstructured":"Dubuisson AS, Beckers A, Stevenaert A (2006) Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg 109(1):63\u201370. https:\/\/doi.org\/10.1016\/j.clineuro.2006.01.006","journal-title":"Clin Neurol Neurosurg"},{"key":"1316_CR10","doi-asserted-by":"publisher","unstructured":"M\u00f6ller-Goede DL, Br\u00e4ndle M, Landau K, Bernays RL, Schmid C (Jan 2011) Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome,\u201c (in eng). Eur J Endocrinol 164(1):37\u201343. https:\/\/doi.org\/10.1530\/EJE-10-0651","DOI":"10.1530\/EJE-10-0651"},{"issue":"3","key":"1316_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2265.2006.02463.x","volume":"64","author":"EH Nielsen","year":"2006","unstructured":"Nielsen EH et al (2006) Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma. Clin Endocrinol (Oxford) 64(3):319\u2013322. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02463.x","journal-title":"Clin Endocrinol (Oxford)"},{"issue":"6","key":"1316_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jocn.2009.11.012","volume":"17","author":"ZH Liu","year":"2010","unstructured":"Liu ZH et al (2010) Clinical features and surgical outcome of clinical and subclinical pituitary apoplexy. J Clin Neurosci 17(6):694\u2013699. https:\/\/doi.org\/10.1016\/j.jocn.2009.11.012","journal-title":"J Clin Neurosci"},{"issue":"5","key":"1316_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1468-1331.2011.03619.x","volume":"19","author":"ZH Liu","year":"2012","unstructured":"Liu ZH, Tu PH, Pai PC, Chen NY, Lee ST, Chuang CC (2012) Predisposing factors of pituitary hemorrhage. Eur J Neurol 19(5):733\u2013738. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03619.x. \/05\/01 2012, doi","journal-title":"Eur J Neurol"},{"key":"1316_CR14","doi-asserted-by":"publisher","unstructured":"Korotinsky S et al (2002) \u201cPituitary apoplexy after administration of heparin and isosorbide dinitrate,\u201c Southern medical journal (Birmingham, Ala.), vol.\u00a095, no. 4, pp.\u00a0469\u2013470, https:\/\/doi.org\/10.1097\/00007611-200204000-00020","DOI":"10.1097\/00007611-200204000-00020"},{"issue":"1","key":"1316_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/heart.89.1.10","volume":"89","author":"DV Nagarajan","year":"2003","unstructured":"Nagarajan DV, Bird D, Papouchado M (2003) Pituitary apoplexy following anticoagulation for acute coronary syndrome. Heart (British Cardiac Society 89(1):10\u201310. https:\/\/doi.org\/10.1136\/heart.89.1.10","journal-title":"Heart (British Cardiac Society"},{"issue":"7","key":"1316_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.1965.03090070073033","volume":"193","author":"AR Nourizadeh","year":"1965","unstructured":"Nourizadeh AR, Pitts FW (1965) Hemorrhage into Pituitary Adenoma during Anticoagulant Therapy. JAMA: the journal of the American Medical Association 193(7):623\u2013625. https:\/\/doi.org\/10.1001\/jama.1965.03090070073033","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"5","key":"1316_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/00000441-199711000-00016","volume":"314","author":"OO Maung Maung","year":"1997","unstructured":"Maung Maung OO, Krishna AY, Bonavita GJ, Rutecki GW (1997) Heparin therapy for myocardial infarction: an unusual trigger for pituitary apoplexy. Am J Med Sci 314(5):351\u2013353. https:\/\/doi.org\/10.1097\/00000441-199711000-00016","journal-title":"Am J Med Sci"},{"key":"1316_CR18","doi-asserted-by":"publisher","unstructured":"Swaid B, Kalaba F, Bachuwa G, Sullivan SE (2019) \u201cHeparin-Induced Pituitary Apoplexy Presenting as Isolated Unilateral Oculomotor Nerve Palsy: A Case Report and Literature Review,\u201c Case reports in endocrinology, vol. pp.\u00a01\u20135, 2019, https:\/\/doi.org\/10.1155\/2019\/5043925","DOI":"10.1155\/2019\/5043925"},{"key":"1316_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1752-1947-1-74","volume":"1","author":"TM Tan","year":"2007","unstructured":"Tan TM, Caputo C, Mehta A, Hatfield EC, Martin NM, Meeran K (2007) Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report,\u201c (in eng). J Med Case Rep 1:74\u201374. https:\/\/doi.org\/10.1186\/1752-1947-1-74","journal-title":"J Med Case Rep"},{"key":"1316_CR20","doi-asserted-by":"publisher","unstructured":"Willamowicz AS, Houlden RL \u201cPituitary apoplexy after anticoagulation for unstable angina,\u201c (in eng), Endocr Pract, vol.\u00a05, no. 5, pp.\u00a0273-6, 1999 Sep-Oct 1999, https:\/\/doi.org\/10.4158\/EP.5.5.273","DOI":"10.4158\/EP.5.5.273"},{"key":"1316_CR21","doi-asserted-by":"publisher","unstructured":"Doglietto F et al (2017) \u201cNew Oral Anticoagulants and Pituitary Apoplexy,\u201c (in eng), World Neurosurg, vol.\u00a0100, p.\u00a0700, 04. https:\/\/doi.org\/10.1016\/j.wneu.2016.12.010","DOI":"10.1016\/j.wneu.2016.12.010"},{"issue":"2","key":"1316_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ncn3.18","volume":"1","author":"M Uemura","year":"2013","unstructured":"Uemura M, Miyashita F, Shimomura R, Fujinami J, Toyoda K (2013) Pituitary apoplexy during treatment with dabigatran. Neurol Clin Neurosci 1(2):82\u201383. https:\/\/doi.org\/10.1002\/ncn3.18","journal-title":"Neurol Clin Neurosci"},{"key":"1316_CR23","doi-asserted-by":"publisher","unstructured":"Ly S et al (2017) \u201cPituitary apoplexy and rivaroxaban,\u201c Pituitary, vol.\u00a020, no. 6, pp.\u00a0709\u2013710, https:\/\/doi.org\/10.1007\/s11102-017-0828-4","DOI":"10.1007\/s11102-017-0828-4"},{"key":"1316_CR24","doi-asserted-by":"publisher","unstructured":"Rivera-Nieves Y et al (2021) \u201cPituitary Apoplexy in the Setting of Oral Anticoagulation Therapy With Apixaban,\u201c Journal of the Endocrine Society, vol.\u00a05, no. Supplement_1, pp. A598-A599, https:\/\/doi.org\/10.1210\/jendso\/bvab048.1220","DOI":"10.1210\/jendso\/bvab048.1220"},{"issue":"8","key":"1316_CR25","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.revmed.2010.01.005","volume":"31","author":"O Dupuy","year":"2010","unstructured":"Dupuy O, Bordier L, Galzin A, Le Berre JP, Mayaudon H, Bauduceau B (2010) Uncommon complication of anticoagulant therapy: pituitary hemorrhage. La revue de medecine interne 31(8):e1","journal-title":"La revue de medecine interne"},{"issue":"12","key":"1316_CR26","doi-asserted-by":"publisher","first-page":"001254","DOI":"10.12890\/2019_001254","volume":"6","author":"AR Santos","year":"2019","unstructured":"Santos AR, Bello CT, Sousa A, Duarte JS, Campos L (2019) Pituitary Apoplexy following systemic anticoagulation,\u201c (in eng). Eur J Case Rep Intern Med 6(12):001254. https:\/\/doi.org\/10.12890\/2019_001254","journal-title":"Eur J Case Rep Intern Med"},{"key":"1316_CR27","doi-asserted-by":"publisher","unstructured":"Scangas GA, Laws ER (2013) \u201cPituitary incidentalomas,\u201c Pituitary, vol.\u00a017, no. 5, pp.\u00a0486\u2013491, https:\/\/doi.org\/10.1007\/s11102-013-0517-x","DOI":"10.1007\/s11102-013-0517-x"},{"key":"1316_CR28","doi-asserted-by":"publisher","unstructured":"Ho KH, van Hove M, Leng G \u201cTrends in anticoagulant prescribing: a review of local policies in English primary care,\u201c BMC Health Services Research, vol.\u00a020, no. 1, p.\u00a0279, 2020\/04\/03 2020, https:\/\/doi.org\/10.1186\/s12913-020-5058-1","DOI":"10.1186\/s12913-020-5058-1"},{"key":"1316_CR29","doi-asserted-by":"publisher","unstructured":"Kozie\u0142 M et al (Aug 2021) Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world,\u201c (in eng). J Arrhythm 37(4):990\u20131006. https:\/\/doi.org\/10.1002\/joa3.12588","DOI":"10.1002\/joa3.12588"},{"key":"1316_CR30","doi-asserted-by":"publisher","unstructured":"Albani A et al (2016) \u201cMultidisciplinary Management of Pituitary Apoplexy,\u201c International journal of endocrinology, vol. pp.\u00a07951536-11, 2016, https:\/\/doi.org\/10.1155\/2016\/7951536","DOI":"10.1155\/2016\/7951536"},{"issue":"7","key":"1316_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40618-015-0424-2","volume":"39","author":"L Giammattei","year":"2016","unstructured":"Giammattei L et al (2016) Pituitary apoplexy: considerations on a single center experience and review of the literature. J Endocrinol Investig 39(7):739\u2013746. https:\/\/doi.org\/10.1007\/s40618-015-0424-2","journal-title":"J Endocrinol Investig"},{"key":"1316_CR32","doi-asserted-by":"publisher","unstructured":"Jho DH, Biller BMK, Agarwalla PK, Swearingen B (2014) \u201cPituitary Apoplexy: Large Surgical Series with Grading System,\u201c World neurosurgery, vol.\u00a082, no. 5, pp.\u00a0781\u2013790, https:\/\/doi.org\/10.1016\/j.wneu.2014.06.005","DOI":"10.1016\/j.wneu.2014.06.005"},{"key":"1316_CR33","doi-asserted-by":"publisher","unstructured":"Mou C, Han T, Zhao H, Wang S, Qu Y (2009) \u201cClinical features and immunohistochemical changes of pituitary apoplexy,\u201c (in eng), J Clin Neurosci, vol.\u00a016, no. 1, pp.\u00a064 \u2013 8, Jan. https:\/\/doi.org\/10.1016\/j.jocn.2008.02.012","DOI":"10.1016\/j.jocn.2008.02.012"},{"key":"1316_CR34","doi-asserted-by":"publisher","unstructured":"Delgado GE et al (2019) \u201cThe association of high-normal international-normalized-ratio (INR) with mortality in patients referred for coronary angiography,\u201c (in eng), PLoS One, vol.\u00a014, no. 8, p. e0221112, https:\/\/doi.org\/10.1371\/journal.pone.0221112","DOI":"10.1371\/journal.pone.0221112"},{"key":"1316_CR35","doi-asserted-by":"publisher","unstructured":"Sibal L et al (2004) \u201cPituitary Apoplexy: A Review of Clinical Presentation, Management and Outcome in 45 Cases,\u201c Pituitary, vol.\u00a07, no. 3, pp.\u00a0157\u2013163, https:\/\/doi.org\/10.1007\/s11102-005-1050-3","DOI":"10.1007\/s11102-005-1050-3"},{"issue":"1","key":"1316_CR36","first-page":"25","volume":"43","author":"LA da Motta","year":"1999","unstructured":"da Motta LA, de Mello PA, de Lacerda CM, Neto AP, da Motta LD, Filho MF (1999) Pituitary apoplexy. Clinical course, endocrine evaluations and treatment analysis. J Neurosurg Sci 43(1):25\u201336","journal-title":"J Neurosurg Sci"},{"key":"1316_CR37","doi-asserted-by":"publisher","unstructured":"Semple PL, Webb MK, de Villiers JC, Laws ER Jr (2005) \u201cPituitary apoplexy,\u201c (in eng), Neurosurgery, vol.\u00a056, no. 1, pp.\u00a065\u201372; discussion 72 \u2013 3, https:\/\/doi.org\/10.1227\/01.neu.0000144840.55247.38","DOI":"10.1227\/01.neu.0000144840.55247.38"},{"issue":"9","key":"1316_CR38","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1210\/jc.2002-020309","volume":"87","author":"CJ McCabe","year":"2002","unstructured":"McCabe CJ et al (2002) Vascular endothelial growth factor, its receptor KDR\/Flk-1, and Pituitary Tumor transforming gene in Pituitary Tumors. J Clin Endocrinol Metab 87(9):4238\u20134244. https:\/\/doi.org\/10.1210\/jc.2002-020309","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01316-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-023-01316-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01316-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T03:15:57Z","timestamp":1690946157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-023-01316-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1316"],"URL":"https:\/\/doi.org\/10.1007\/s11102-023-01316-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2583793\/v1","asserted-by":"object"}]},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"9 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Institutional Review Board approval was obtained from The University of Texas Health Science Center Committee for the Protection of Human Subjects (HSC-MS-19-0697).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Due to the retrospective nature of this study, informed consent was waived by the Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"No authors have any financial or non-financial interests that are directly or indirectly related to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}